These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25863450)

  • 1. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary!
    Lombardi C
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):530-1. PubMed ID: 25863450
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cells in allergen-specific immunotherapy.
    Novak N
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():91-2. PubMed ID: 19221629
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
    Kleine-Tebbe J
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 6. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen immunotherapy: an updated review of safety.
    James C; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different methods of local allergen-specific immunotherapy.
    Kägi MK; Wüthrich B
    Allergy; 2002 May; 57(5):379-88. PubMed ID: 11972476
    [No Abstract]   [Full Text] [Related]  

  • 9. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
    Bauer CS; Rank MA
    J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of immunotherapy delivery methods for allergen immunotherapy.
    Klimek L; Pfaar O
    Expert Rev Clin Immunol; 2013 May; 9(5):465-74; quiz 475. PubMed ID: 23634740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
    Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
    [No Abstract]   [Full Text] [Related]  

  • 14. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcutaneous injection immunotherapy for optimal effectiveness.
    Nelson HS
    Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different immunotherapy applications--different mechanisms? SLIT versus SCIT--differences in the mode of action.
    Allam JP; Bieber T; Novak N
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():237-40; discussion 240-5. PubMed ID: 20799467
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of subcutaneous and sublingual immunotherapy with recombinant allergens.
    Jutel M; Solarewicz-Madejek K; Smolinska S
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():133-9. PubMed ID: 24912327
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous administration of allergen vaccines.
    Radtke M; Grammer LC
    Clin Allergy Immunol; 2008; 21():321-32. PubMed ID: 18828514
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local immunotherapy in allergy.
    Morris DL; Kroker GF; Sabnis VK; Morris MS
    Chem Immunol Allergy; 2003; 82():1-10. PubMed ID: 12947987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.